3 Quantum Computing Stocks Down Sharply -- but 1 Offers Exceptional Value

The article argues that quantum computing stocks have undergone a valuation reset despite improving business metrics, highlighting IonQ’s $64.7 million Q1 revenue, 755% year-over-year growth, $470 million backlog, and raised 2026 guidance to $260 million-$270 million. D-Wave stands out with $33.4 million in bookings, up 1,994% year over year, plus major contracts including a $20 million system sale and a $10 million QaaS deal, while Rigetti remains early with just $4.4 million in Q1 revenue. Overall, the piece favors D-Wave on commercial momentum but remains cautious on the sector’s rich valuations and share-price volatility.

Analysis

The sector is transitioning from “technology optionality” to “commercial proof,” and that shift should widen dispersion rather than lift all boats. The market is now rewarding backlog conversion and contracted revenue visibility more than raw technical milestones, which structurally favors QBTS over RGTIW because bookings can re-rate before reported revenue catches up. That also means the next leg higher in the group will likely come from evidence of monetization cadence, not another demo or roadmap update.

IONQ looks like the highest-quality asset, but the setup is deteriorating from a marginal buyer’s perspective: the business can keep compounding while the multiple compresses. The key second-order risk is that every additional capital raise or public competitor filing raises the bar for “category winner” status, pushing investors to demand closer proof of unit economics and deployment scale. In practice, that caps near-term upside even if fundamentals remain strong.

QBTS is the most interesting asymmetry because the market appears to be valuing it as if bookings are nonrecurring or heavily back-end loaded. If even a portion of its contract wins convert on schedule over the next 2-3 quarters, revenue inflection could arrive abruptly and force sell-side revisions upward. The principal tail risk is execution slippage: if conversion timing moves right, the stock can cheapen quickly because the current setup is predicated on a second-half ramp.

RGTIW is the cleanest short on valuation-versus-monetization mismatch, but it is not a timing vehicle for earnings alone because the cash balance reduces near-term distress risk. The better bearish angle is relative underperformance versus names with visible booking momentum, not bankruptcy risk. HON is only a secondary winner via strategic exposure to private-market quantum infrastructure, while NVDA/INTC are mostly sentiment beneficiaries unless enterprise adoption broadens materially.

Key Decisions for Investors

• Long QBTS vs short RGTIW as a 3-6 month pair trade: express the view that bookings-to-revenue conversion matters more than technical milestones; target 20-30% relative outperformance if second-half revenue ramps.
• Buy QBTS on post-selloff weakness with a 90-day horizon: risk/reward improves if the market keeps discounting bookings, while upside comes from backlog conversion and guidance credibility; size modestly because timing risk is high.
• Avoid chasing IONQ at current levels; instead, use it as a short-call overlay or covered-call candidate for 1-2 quarters to monetize premium while waiting for a better entry. The stock can still work fundamentally, but the multiple leaves limited near-term convexity.
• Maintain a tactical short or underweight in RGTIW for 1-3 months against a basket of better monetizing quantum names; thesis is not technology failure but valuation compression as revenue remains too small to support the current equity story.
• For risk-tolerant accounts, consider a call spread in QBTS out 4-6 months to capture a potential re-rating from contract conversion while limiting downside if execution slips.